(NewsDirect)
Emergent HealthCorp . (OTC: EMGE) , a curator, developer, and marketer ofproducts in the Regenerative Health Space, is pleased to announce thatit has regained its “Pink Current Information” status with the OTCMarkets, a major milestone in the company's continued growth anddevelopment and is now current with all required mandatory disclosurefilings again.
Jim Morrison, former L'Oréal President and Emergent’sfull-time CEO stated “We’ve been working diligently with OTCMarkets since being classified as “Pink Sheet Limited Information”several weeks ago and took all the necessary steps to regain “PinkCurrent Information” status. Achieving this status is a testament toEmergent’s commitment to excellence and full transparency with theintent to create long-term trust and value for our shareholders.Moving forward, we have taken steps to ensure this never occurs againwith regard to OTC Market mandatory disclosure requirements. Thisachievement would not have been possible without the hard work anddedication of our entire team, and we are grateful for theirefforts”.
Yesterday on May 2, 2023, Emergent announced revenues of$373,406 for the quarter ended December 31, 2022 as compared to$185,471 for the quarter ended September 30, 2022, an increase of over100% and revenues of $574,613 for the Year Ended December 31, 2022 ascompared to $119,567 for the year ended December 31, 2021, an increaseof over 380%. The financial statement can be viewed in its entirety at OTCMarkets .
Theglobal b iologicsmarket size was valued at US $366.43 billion in 2021 and it isexpected to hit over US$ 719.84 billion by 2030 with a noteworthy CAGRof 7.8% from 2022 to 2030. A biologic medication is a product that ismade from live organisms and contains living organism components.Examples of biologics are Recombinant protein, tissues, allergens,genes, cells, blood components, blood, and vaccinations are allexamples of biologics. Examples of what can be treated are Anemia,hemophilia, chronic migraine, hepatitis B, rheumatoid arthritis,inflammatory bowel disease, and other disorders and infections aretreated with biologics. Our focus is on aesthetics cosmetics andmen’s and women’s health, but also wound care and tissueregeneration. Various government efforts, higher share of biologics inthe market, and rising use of biopharmaceuticals over chemicallyproduced molecules, and many other factors are driving the biologicsmarket expansion in the forecast period.
ABOUT EMERGENT HEALTHCORPORATION
Emergent curates, develops and sells products in theRegenerative Health Space. Its products comprise of ingestibles aswell as topicals for the whole family. The company distributes itsproducts online and through Content Based Shopping using Influencersto position products in their produced content throughout the UnitedStates and Internationally. Its subsidiaries; PharmaZu , is apure play, e-commerce products and service provider focused on the PetCommunity, Pet Pharmacy and Pet Wellness using Influencers and theircontent, including the pet pharmacy, vet telehealth and pet wellnessbusinesses; Regen BioWellness, is a distributor of various products inthe plant-based and regenerative medical fields. EvolutionaryBiologics , is a new kind of biologics company founded for aclear purpose: bring cutting edge regenerative products to the medicalcommunity. Emergent does not claim any of its products are approved bythe FDA to diagnose, treat, cure or prevent any disease. For moreinformation, please visit Emergent's Website andSocial Media on .
Before using anyproducts, you should always consult with your Veterinarian and/orFamily Doctor.
SAFE HARBOR STATEMENT
This press release contains forward-lookingstatements that can be identified by terminology such as“believes,” “expects,” “potential,” “plans,”“suggests,” “may,” “should,” “could,” “intends,”or similar expressions. Many forward-looking statements involve knownand unknown risks, uncertainties and other factors that may causeactual results to be materially different from any future resultsimplied by such statements. These factors include, but are not limitedto, our ability to continue to enhance our products and systems toaddress industry changes, our ability to expand our customer base andretain existing customers, our ability to effectively compete in ourmarket segment, the lack of public information on our company, ourability to raise sufficient capital to fund our business, operations,our ability to continue as a going concern, and a limited publicmarket for our common stock, among other risks. Many factors aredifficult to predict accurately and are generally beyond thecompany's control. Forward-looking statements speak only as to thedate they are made, and we do not undertake to update forward-lookingstatements to reflect circumstances or events that occur after thedate the forward-looking statements are made.
FOR MOREINFORMATION, PLEASE CONTACT:
Jim Morrison, CEO
Emergent HealthCorporation Website
i nfo@emergenthealthcompany.com
ContactDetails
Emergent Health Corp.
info@emergenthealthcompany.com
CompanyWebsite
https://emergenthealthcompany.com/
Copyright (c) 2023 TheNewswire - All rights reserved.